M. Marvisi (Salsomaggiore Terme, Italy), C. Tantucci (Brescia, Italy)
Use of beta-blockers in COPD patients with heart-disease. BBEPOC study
P. Sobradillo, A. Fuster, P. J. Marcos, A. Ortega, C. González, M. Aburto, J. L. Rodríguez, B. Alcázar, M. Calle, L. Puente (Vitoria, Palma de Mallorca, A coruña, M, Valencia, Galdakao, Madrid, Granada, Spain)
|   |
Mapping of COPD guideline adherence in primary care: An observational study in Belgium and Luxembourg
W. Vincken, R. Peché, M. Potvin, A. Albert, M. Schlesser (Brussels, Montigny-le-Tilleul, Wilrijk, Liège, Belgium; Luxembourg, Luxembourg)
|  |
Bullous emphysema and severe COPD in acetylated opium users
M. Sanzharovskaya, E. Budankova, A. Fisenko, E. Kuzin, E. Ustyuzhanina, G. Chernyavskaya, G. Chernogoryuk (Tomsk, Russian Federation)
| |
Elevated circulating CTLA-4 level in patients with COPD is related to systemic inflammation and disease severity
L. Jia, Y. Shen, H. Long, C. Pang, F. Wen, T. Wang (Chengdu, China)
| |
Relationship between plasma amino acid levels and lung function decline in patients with COPD
M. Suzuki, H. Makita, S. Konno, K. Nagai, M. Nishimura (Sapporo, Japan)
| |
The species-specific inflammatory response of colonising bacteria in stable COPD
R. Singh, A. Patel, A. Mackay, D. Garcha, B. Kowlessar, S. Brill, R. Sapsford, L. Donnelly, P. Barnes, G. Donaldson, J. Wedzicha (London, United Kingdom)
| |
Is hyaluronic acid (HA) a marker of effectiveness of anti-inflammatory therapy in COPD patients?
B. Basina, T. Pertseva, L. Konopkina (Dnipropetrovsk, Ukraine)
| |
Predictors of readmission after hospitalization for acute exacerbations of chronic obstructive pulmonary disease (AECOPD)
R. T. M. Sprooten, R. H. J. Slenter, D. Kotz, G. Wesseling, E. F. M. Wouters, G. G. U. Rohde (Maastricht, Netherlands)
| |